Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis
- PMID: 22492316
- DOI: 10.1002/ijc.27589
Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis
Abstract
Autophagy is known to have a cytoprotective role under various cellular stresses; however, it also results in robust cell death as an important safeguard mechanism that protects the organism against invading pathogens and unwanted cancer cells. Autophagy is regulated by cell signalling including microRNA (miRNA), a post-transcriptional regulator of gene expression. Here, we show that genetically engineered telomerase-specific oncolytic adenovirus induced miR-7 expression, which is significantly associated with its cytopathic activity in human cancer cells. Virus-mediated miR-7 upregulation depended on enhanced expression of the E2F1 protein. Ectopic expression of miR-7 suppressed cell viability and induced autophagy by inhibiting epidermal growth factor receptor (EGFR) expression. Our results suggest that oncolytic adenovirus induces autophagic cell death through an E2F1-miR-7-EGFR pathway in human cancer cells, providing a novel insight into the molecular mechanism of an anticancer virotherapy.
Copyright © 2012 UICC.
Similar articles
-
Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.Int J Mol Sci. 2017 Jul 10;18(7):1479. doi: 10.3390/ijms18071479. Int J Mol Sci. 2017. PMID: 28698504 Free PMC article. Review.
-
Oncolytic adenovirus-induced autophagy: tumor-suppressive effect and molecular basis.Acta Med Okayama. 2013;67(6):333-42. doi: 10.18926/AMO/52006. Acta Med Okayama. 2013. PMID: 24356717 Review.
-
Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.Int J Mol Med. 2013 Feb;31(2):377-85. doi: 10.3892/ijmm.2012.1197. Epub 2012 Nov 29. Int J Mol Med. 2013. PMID: 23229955
-
Oncolytic adenoviruses for the treatment of brain tumors.Curr Opin Mol Ther. 2010 Oct;12(5):530-7. Curr Opin Mol Ther. 2010. PMID: 20886384 Review.
-
Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.Int J Cancer. 2015 May 1;136(9):2228-40. doi: 10.1002/ijc.29258. Epub 2014 Nov 12. Int J Cancer. 2015. PMID: 25303768
Cited by
-
Mitophagy switches cell death from apoptosis to necrosis in NSCLC cells treated with oncolytic measles virus.Oncotarget. 2014 Jun 15;5(11):3907-18. doi: 10.18632/oncotarget.2028. Oncotarget. 2014. PMID: 25004098 Free PMC article.
-
Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody.Mol Ther. 2020 Mar 4;28(3):794-804. doi: 10.1016/j.ymthe.2020.01.003. Epub 2020 Jan 10. Mol Ther. 2020. PMID: 31991110 Free PMC article.
-
A new paradigm for epidermal growth factor receptor expression exists in PTC and NIFTP regulated by microRNAs.Front Oncol. 2023 Apr 11;13:1080008. doi: 10.3389/fonc.2023.1080008. eCollection 2023. Front Oncol. 2023. PMID: 37114127 Free PMC article.
-
Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.Int J Mol Sci. 2017 Jul 10;18(7):1479. doi: 10.3390/ijms18071479. Int J Mol Sci. 2017. PMID: 28698504 Free PMC article. Review.
-
MicroRNA: a third dimension in autophagy.Cell Cycle. 2013 Jan 15;12(2):246-50. doi: 10.4161/cc.23273. Epub 2012 Jan 15. Cell Cycle. 2013. PMID: 23255136 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous